NanoVector to Commercialize First Biologic Nanoparticle Drug Delivery System
12/2/2008 10:22:18 AM
RALEIGH, N.C.--(BUSINESS WIRE)--NanoVector, Inc. announced today that it has licensed the plant virus nanoparticle drug delivery system developed by Professors’ Stefan Franzen and Steven Lommel from North Carolina State University. “This is breakaway technology that will finally provide the highly sought after selective targeting of tumors and intracellular delivery of anti-cancer agents for improved efficacy and fewer unpleasant side effects,” said Albert Bender, Ph.D., NanoVector CEO. “The plant virus nanoparticle has evolved over millions of years to have several inherent characteristics essential for a successful nanoparticle delivery system and superior to any chemistry based nanoparticle designed and engineered by humans.” continued Dr. Bender.
comments powered by